Tuesday, June 6, 2023
No Result
View All Result
  • বাংলা সংস্করণ
Shomporko
Advertisement
  • Home
  • News
    • Daily News
    • Feature
    • Sports
  • CANADA
    • Canada Daily
    • Community News
    • Canada Politics
    • Canada Economy
    • Canada Health
  • Global
  • Bangladesh
  • Interview
  • Article
    • Analytical
  • LITERATURE
    • Story
    • Poem
  • Opinion
    • Columnists
  • More
    • Food & Beverage
    • HISTORY
    • Kids Page
    • Travel
    • HOME DECOR
    • Video
    • Social Media
    • Festival
  • Home
  • News
    • Daily News
    • Feature
    • Sports
  • CANADA
    • Canada Daily
    • Community News
    • Canada Politics
    • Canada Economy
    • Canada Health
  • Global
  • Bangladesh
  • Interview
  • Article
    • Analytical
  • LITERATURE
    • Story
    • Poem
  • Opinion
    • Columnists
  • More
    • Food & Beverage
    • HISTORY
    • Kids Page
    • Travel
    • HOME DECOR
    • Video
    • Social Media
    • Festival
No Result
View All Result
Shomporko
No Result
View All Result
Home Canada Daily

Toronto boy with ultra-rare disease receives groundbreaking gene therapy, funds being raised to help others with SPG50

by Shomporko Online News Desk
August 15, 2022
in Canada Daily, Dailynews
0
Toronto boy with ultra-rare disease receives groundbreaking gene therapy, funds being raised to help others with SPG50
0
SHARES
27
VIEWS
Share on FacebookShare on Twitter

The heartbreaking quest of a Toronto family to find a treatment for their son’s extremely uncommon ailment has reached a new high point.

In the past few months, four-year-old Michael Pirovolakis became the first person in the world to get personalised gene therapy for spastic paraplegia type 50, or SPG50, after more than three years of rigorous fundraising and equally arduous research for a potential solution.

This complicated neurogenerative disorder, which is brought on by the absence of a protein in the brain, causes severe developmental delays, leg stiffness and weakness that proceed to paralysis by the age of ten.

Around the world, 80 kids are estimated to have SPG50. Michael, however, is thought to be the only patient in Canada who has the illness.The Pirovolakis family, who live in East York, learned Michael had SPG50 when he was just over a year old.

Determined to help their son, Terry and Georgia Pirovolakis immediately got to work to raise more than US$3 million needed to pay for the experimental treatment that could stop the progression of and maybe even cure their son’s disease.

Navigating the complexities of creating a cure for an ultra-rare illness, especially during a global pandemic, was no easy feat, Terry Pirovolakis admitted.

“It’s been a pretty long journey with lots of ups and down and then delays with COVID,” he said.

“We’re very grateful for our team. For every setback we always had a plan to move forward. We were always hopeful that everything remained on track.”

In December 2020, researchers created a prototype for the treatment and successfully tested it on animals in a laboratory.

Just over a year later on Dec. 30, 2021, Health Canada approved the first human SPG50 clinical trial. The new gene therapy was injected into Michael’s spinal canal at Toronto’s Hospital for Sick Children on March 24.

Dr. Jim Dowling, staff physician at SickKids’ Division of Neurology and a senior scientist in the hospital’s Genetics & Genome Biology program, led Michael’s clinical trial.

Pirovolakis said its all about giving Michael and others with ultra-rare illnesses a “better life.”

His son’s medical team agrees.

“Successfully conducting the trial for Michael was not only a key milestone for him and his family but also for achieving SickKids’ vision for Precision Child Health, a movement to deliver individualized care for every patient,” Dr. David Malkin, who is the CIBC Children’s Foundation Chair in Child Health Research at SickKids, said in a news release.

“Not only can rare diseases be a springboard to figure out how to treat more common conditions, but learnings from Michael’s trial will help carve out a path for SickKids to explore innovative, precision-based treatment options for other patients with rare, genetic diseases.”

Source_globalnews.ca

Previous Post

Dozens of families scrambling to find new child care provider after Ajax daycare forced to close by end of month

Next Post

Peel homicide squad investigating after man, woman found dead inside Mississauga home

Shomporko Online News Desk

Related Posts

NORAD says storm won’t slow Santa’s travels
Canada Daily

NORAD says storm won’t slow Santa’s travels

December 25, 2022
Catholics return to GTA churches for full-capacity Christmas masses
Canada Daily

Catholics return to GTA churches for full-capacity Christmas masses

December 25, 2022
List of GTA school cancellations during holiday winter storm
Canada Daily

List of GTA school cancellations during holiday winter storm

December 23, 2022
Toronto could still be digging out from major winter storm on Christmas Day, city officials warn
Canada Daily

Toronto could still be digging out from major winter storm on Christmas Day, city officials warn

December 23, 2022
Popular arena in the Junction to close unexpectedly for months due to emergency roof repairs
Canada Daily

Popular arena in the Junction to close unexpectedly for months due to emergency roof repairs

December 22, 2022
Woman, child seriously injured after being hit by vehicle in Cedarvale
Canada Daily

Woman, child seriously injured after being hit by vehicle in Cedarvale

December 22, 2022
Next Post
Peel homicide squad investigating after man, woman found dead inside Mississauga home

Peel homicide squad investigating after man, woman found dead inside Mississauga home

Logo

Disclaimer:

The editorial team is not responsible for the content of the writing.

Publisher and Editor
Sonia Hoque

General Manager

Rewrite-Man

Reporter

Graphics
Mozammel Sarkar

Address:

Shomporko Magazine

59 Byng ave
Scarborough,
Ontario
M1L3N8

Phone :647-686-5432

 

Email: 
shomporko.magazine@gmail.com
2537765 Ontario Ltd

© 2020 Shomporko – Magazine Develop by RMITtech

No Result
View All Result
  • Home
  • NEWS
    • Daily News
    • Feature
    • Global
    • Politics
    • Sports
  • CANADA
    • Canada Daily
    • Community News
    • Canada Politics
    • Canada Economy
    • Canada Immigration
    • Canada Education
    • Canada Health
    • Canada Opinion
  • GLOBAL
  • INTERVIEW
  • ARTICLE
    • Analytical
  • LITERATURE
    • Story
    • Poem
  • OPINION
    • Opinion
    • Columnists
    • Legal Advice
  • ARTS
    • Home Decor
    • Sports
  • LIVING
    • Health
    • Food
    • Travel
    • HISTORY
    • Kids Page
  • MORE
    • Video
    • Social Media
    • Festival
  • বাংলা সংস্করণ

© 2019 Shomporko - Magazine Develop by RMITtech.

Translate »